Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)
Status:
Recruiting
Trial end date:
2023-01-02
Target enrollment:
Participant gender:
Summary
This is a 16-week study in adult participants with chronic hand eczema (CHE). The
participants will visit the clinic regularly to have the study doctor assess their CHE and to
answer questions about itch, pain, CHE symptoms, and quality of life.
The purpose is to assess how delgocitinib cream works to treat CHE when compared to a placebo
cream with no active substance.